Evidence map›Paper›PMID 28342293›Full record

ArticleThe FEBS journal2017

Ribosomal protein L7/L12 is required for GTPase translation factors EF-G, RF3, and IF2 to bind in their GTP state to 70S ribosomes.

Markus A Carlson, Bassam G Haddad, Amanda J Weis, Colby S Blackwood, Catherine D Shelton, Michelle E Wuerth, Justin D Walter, Paul Clint Spiegel

Open access · bronzeAbstract readEditorial
In one paragraph

Article in The FEBS journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Characterization ofInternational journal of molecular sciences · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Extraribosomal Functions of Bacterial Ribosomal Proteins-An Update, 2023.International journal of molecular sciences · 2024
    Review
  9. Article
  10. Article
  11. Archaea/eukaryote-specific ribosomal proteins - guardians of a complex structure.Computational and structural biotechnology journal · 2023
    Review
  12. Immuno-profiling ofFrontiers in microbiology · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The Diseased Mitoribosome.FEBS letters · 2021
    Review
  19. Article
  20. Direct visualization of translational GTPase factor pool formed around the archaeal ribosomal P-stalk by high-speed AFM.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Markus A CarlsonDepartment of Chemistry, Western Washington University, Bellingham, WA, USA.
Bassam G HaddadDepartment of Chemistry, Western Washington University, Bellingham, WA, USA.
Amanda J WeisDepartment of Chemistry, Western Washington University, Bellingham, WA, USA.
Colby S BlackwoodDepartment of Chemistry, Western Washington University, Bellingham, WA, USA.
Catherine D SheltonDepartment of Chemistry, Western Washington University, Bellingham, WA, USA.
Michelle E WuerthDepartment of Chemistry, Western Washington University, Bellingham, WA, USA.
Justin D WalterDepartment of Chemistry, Western Washington University, Bellingham, WA, USA.
Paul Clint SpiegelDepartment of Chemistry, Western Washington University, Bellingham, WA, USA.
Western Washington University · US

Funding

Structural Requirements for Ribosome-Dependent GTPase Activation and Hybrid StateR15GM109387 · NIGMS · WESTERN WASHINGTON UNIVERSITY · PI SPIEGEL, PAUL CLINTON · 2014 to 2014
$284k
NIGMS NIH HHS R15 GM109387
6 · The paper itself

Abstract

Ribosomal protein L7/L12 is associated with translation initiation, elongation, and termination by the 70S ribosome. The guanosine 5' triphosphate hydrolase (GTPase) activity of elongation factor G (EF-G) requires the presence of L7/L12, which is critical for ribosomal translocation. Here, we have developed new methods for the complete depletion of L7/L12 from Escherichia coli 70S ribosomes to analyze the effect of L7/L12 on the activities of the GTPase factors EF-G, RF3, IF2, and LepA. Upon removal of L7/L12 from ribosomes, the GTPase activities of EF-G, RF3, and IF2 decreased to basal levels, while the activity of LepA decreased marginally. Upon reconstitution of ribosomes with recombinant L12, the GTPase activities of all GTPases returned to full activity. Moreover, ribosome binding assays indicated that EF-G, RF3, and IF2 require L7/L12 for stable binding in the GTP state, and LepA retained > 50% binding. Lastly, an EF-G∆G' truncation mutant possessed ribosome-dependent GTPase activity, which was insensitive to L7/L12. Our results indicate that L7/L12 is required for stable binding of ribosome-dependent GTPases that harbor direct interactions to the L7/L12 C-terminal domains, either through a G' domain (EF-G, RF3) or a unique N-terminal domain (IF2). Furthermore, we hypothesize this interaction is concomitant with counterclockwise ribosomal intersubunit rotation, which is required for translocation, initiation, and post-termination.

Indexed as

Enzyme ActivationEscherichia coli ProteinsGuanosine TriphosphateHydrolysisMutagenesis, Site-DirectedPeptide Elongation Factor GPeptide Initiation FactorsPeptide Termination FactorsProkaryotic Initiation Factor-2Recombinant ProteinsRibosomal ProteinsRibosomesEscherichia coli ProteinsGuanosine TriphosphateLepA protein, E coliPeptide Elongation Factor GPeptide Initiation FactorsPeptide Termination FactorsprfC protein, E coliProkaryotic Initiation Factor-2Recombinant ProteinsRibosomal ProteinsrplL protein, E colielongation factor GGTPaseprotein L7/L12ribosometranslation

Identifiers

PMID28342293
PMCPMC5568246
OpenAlexW2598125342

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.